AQR Capital Management »

Urogen Pharma shares owned by AQR Capital Management

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $276k 18k 15.00

More positions owned by AQR Capital Management

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Cisco Systems (CSCO)
Adobe Systems Incorporated (ADBE)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Pulte (PHM)
Cigna Corp (CI)
Humana (HUM)
CVS Caremark Corporation (CVS)

View all positions for AQR Capital Management

Top funds holding Urogen Pharma

RA Capital Management
Dr. Jeffrey R. Jay, M.D.
Credit Suisse
Harel Insurance Investments & Financial Services
Migdal Insurance & Financial Holdings
Millennium Management
Opaleye Management
Superstring Capital Management
Laurion Capital Management
Wells Fargo & Company
Citadel Advisors
Vanguard Group
ARK Investment Management
AlphaCentric Advisors
Schonfeld Strategic Advisors

View all funds holding Urogen Pharma